The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 331:131-132 July 14, 1994 Number 2
NextNext

Hyperandrogenism in Polycystic Ovary Syndrome

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Rodin, A.
-PubMed Citation
To the Editor: Rodin et al. (Feb. 17 issue)1 postulate the dysregulation of 11{beta}-hydroxysteroid dehydrogenase in some women with the polycystic ovary syndrome. The interconversion of cortisol and hormonally inactive cortisone is catalyzed by at least two isoforms of 11{beta}-hydroxysteroid dehydrogenase, a nicotinamide-adenine dinucleotide-dependent, unidirectional dehydrogenase (type 2) found predominantly in the placenta and kidneys, and the type 1 enzyme, which has both NADP-dependent dehydrogenase and 11-oxo-reductase activity and is found predominantly in the liver and gonads. The contribution of each type of enzyme to the urinary ratios of 11-oxo to 11-hydroxy metabolites of cortisol and corticosterone used . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.